Items Tagged ‘Other News Topics (not Types of Cancer)’

December 7th, 2017

FDA and CMS Collaborate to Make Novel Cancer Biomarker Test Available

By

The U.S. Food and Drug Administration (FDA) has approved the F1CDx biomarker test designed to detect mutations in 324 genes and two genomic signatures in cancer patients. In a truly collaborative effort between the FDA and The Centers for Medicare & Medicaid Services (CMS) the latter proposed coverage of the F1CDx test under the new […]

View full entry

Tags: biomarker testing, CMS, foundation medicine, General, genomic testing, immunotherapy, KEYNOTE-028, News, Other News Topics (not Types of Cancer), PD-L1 positive, Precision Cancer Medicine, SCLS


July 19th, 2017

New Study Suggests Most Cancers are Unavoidable Irrespective of Life Style

By

Two thirds of cancers are unavoidable even if you live a healthy life, according to a study published by doctors from John Hopkins.  The research, published in the journal Science, indicates that the majority of cancer-causing mutations are due to DNA copying errors. The recent discovery challenges the widespread belief that cancer mutations are generally inherited or triggered […]

View full entry

Tags: All Cancer Types, General, genetic risk of cancer, News, Other News Topics (not Types of Cancer), Precision Cancer Medicine


April 21st, 2017

Immunotherapy for Glioblastoma Well Tolerated; Survival Gains Observed

By

Small, phase one trial of a dendritic cell vaccine supports further study in larger trials A phase one study of 11 patients with glioblastoma who received injections of an investigational vaccine therapy and an approved chemotherapy showed the combination to be well tolerated while also resulting in unexpectedly significant survival increases, researchers at the Duke […]

View full entry

Tags: General, glioblastoma, immunotherapy, News, Other News Topics (not Types of Cancer)


March 23rd, 2017

SWOG Launches National Immunotherapy Clinical Trial for Rare Cancers

By

People with rare cancers now have the option of joining a national clinical trial testing leading-edge immunotherapies for a wide variety of tumor types. It’s the first federally funded immunotherapy trial devoted to rare cancers. Despite their name, rare cancers make up more than 20 percent of cancers diagnosed worldwide. The trial is called DART, […]

View full entry

Tags: All Cancer Types, General, immunotherapy, keytruda, Neuroblastoma, News, Other News Topics (not Types of Cancer), Retinoblastoma, Sarcoma, Vaginal Cancer


March 1st, 2017

Xermelo-new option for controlling symptoms of Carcinoid Syndrome

By

The US Food and Drug Administration (FDA) today approved the oral therapy Xermelo (telotristat ethyl) to be used in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea. Carcinoid syndrome is a cluster of symptoms that occurs in patients with advanced neuroendocrine tumors (NET) and the related diarrhea results […]

View full entry

Tags: carcinoid syndrome, General, NET, neuroendocrine tumors, News, Other News Topics (not Types of Cancer), Xermelo


February 23rd, 2017

Cancer Connect Launches On line Community for Patients with Neuroendocrine Tumors

By

Sun Valley ID & Austin TX— OMNI Health Media (OMNI) announces the launch of a new online community on CancerConnect for individuals with neuroendocrine tumors (NET). This community will provide patients and their loved ones with information and support. Join the conversation in the NET community here. Although neuroendocrine tumors have historically been considered rare, […]

View full entry

Tags: General, neuroendocrine tumors, News, Other News Topics (not Types of Cancer)


October 7th, 2016

It’s in the Genes: Genetic Testing Tutorial

By

Advances in genetic testing are offering women more information than ever before about their genetic makeup and are providing opportunities for empowered decision making related to a wide range of health issues. In this recurring column, experts provide vital information about how genetic testing suits one’s individual needs, potential risks and benefits, and the role […]

View full entry

Tags: General, News, Other News Topics (not Types of Cancer)


September 21st, 2015

Varubi Approved for Chemotherapy-Induced Nausea and Vomiting

By

The United States Food and Drug Administration (FDA) approved the agent Varubi (rolapitant) to be used to prevent delayed phase chemotherapy-induced nausea and vomiting (emesis). Chemotherapy-induced nausea and vomiting (CINV) is a common side effect of treatment with chemotherapy among cancer patients. It can become a serious side effect in that it can cause dehydration, electrolyte […]

View full entry

Tags: chemotherapy-induced, CINV, clinical trial, nausea, Other News Topics (not Types of Cancer), rolapitant, Varubi, vomiting


August 19th, 2015

Smoking Cessation Drug Not Boosting Number of Smokers Who Quit

By

The introduction of a new prescription smoking-cessation aid, varenicline, in 2006 has had no significant impact on the rate at which Americans age 18 and older successfully quit smoking, according to a study led by researchers at University of California, San Diego School of Medicine. The findings, published online August 17 in Tobacco Control, suggest […]

View full entry

Tags: cessation aides, Chantix, General, Other News Topics (not Types of Cancer), quit smoking, tobacco control, varenicline


August 12th, 2015

FDA Designates Breakthrough Therapy Designation for Azedra in Pheochromocytoma and Paraganglioma

By

The U.S. Food and Drug Administration (FDA) has designated Azedra as a Breakthrough Therapy for the treatment of patients with iobenguane-avid metastatic or recurrent pheochromocytoma and paraganglioma. Azedra is currently being evaluated in a pivotal Phase 2b trial, which is being conducted under a Special Protocol Assessment Agreement (SPA), and has received Orphan Drug and […]

View full entry

Tags: azedra, General, News, Other News Topics (not Types of Cancer), Paraganglioma, Pheochromocytoma


July 13th, 2015

theGIConnection and the Inflammatory Bowel Disease Support Foundation Partner to Provide Crohn’s Disease and Ulcerative Colitis Patients with Virtual Support Community

By

July 13, 2015 – Fort Worth TX/Sun Valley ID —OMNI Health Media (OMNI) and the Inflammatory Bowel Disease Support Foundation (IBDSF) are pleased to announce a partnership with TheGIConnection that will both improve access to and increase support of patients and their families impacted by a diagnosis of Crohn’s disease or ulcerative colitis, collectively known as […]

View full entry

Tags: Chron's disease, General, Inflammatory Bowel Disease Support Foundation, online community, Other News Topics (not Types of Cancer), theGIConnection, ulcerative colitis


June 17th, 2015

BCM Study Findings Show That a Mother’s Diet Before Pregnancy May Affect Her Child’s Lifelong Cancer Risk

By

A collaborative team of international researchers led by Dr. Robert Waterland, PhD, associate professor of pediatrics and nutrition at Baylor College of Medicine (BCM) and the USDA/ARS Children’s Nutrition Research Center at Baylor and Texas Children’s Hospital, has made an important discovery that may lead to significant changes in how the medical establishment views the importance of a […]

View full entry

Tags: News, nutritional intake, Other News Topics (not Types of Cancer), pregnancy, tumor suppressor, VTRNA2-1


November 10th, 2014

Tips for Cancer Caregivers: November is National Family Caregiver Month

By

Caring for a family member or friend with cancer is often very challenging. The experience can be exhausting both mentally and physically, but it actually becomes even more so when you don’t take care of yourself. I use a metaphor of a watering can and a garden to drive home this point. If your loved […]

View full entry

Tags: All Cancer Types, cancer caregiver, caregiver, caregiver support, General, News, Other News Topics (not Types of Cancer), support, Types of Cancer


October 15th, 2014

Study Suggest That Psoriasis Patients Have Increased Cancer Risk

By

Based on recently analyzed data from a retrospective analysis of commercial insurance claims, rates of cancer are higher in patients with psoriasis and that some anti-psoriatic drugs may pose a higher risk than others. Dr. Alexa B. Kimball of Massachusetts General Hospital reported at the American Academy of Dermatology summer meeting that rates for all […]

View full entry

Tags: cancer, General, News, Other News Topics (not Types of Cancer), psoriasis


October 14th, 2014

Anamorelin May Be First Drug to Treat Cancer Cachexia

By

A new drug, anamorelin, may be the first ever to effectively improve cancer cachexia. These findings were presented at the 2014 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, September 26–30.[1] Cancer cachexia is a “wasting” condition in which the patient progressively loses significant amounts of bodyweight and muscle mass and suffers from […]

View full entry

Tags: anamorelin, appetite, cachexia, cancer, General, Lung Cancer - Non-Small Cell, News, nutrition, Other News Topics (not Types of Cancer), Stages IIIB-IV Lung Cancer - Non-Small Cell